A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD Mice

Overview of attention for article published in Diabetes, December 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 1,070 followers.

A Preclinical Consortium Approach for Assessing the Efficacy of Combined An... https://t.co/jobhITW12H #diabetes | https://t.co/5vSgyP2j2g

A Preclinical Consortium Approach for Assessing the Eff... https://t.co/2RPmtNoFfW via @billballentine #diabetes

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.